首页> 美国卫生研究院文献>Clinical Cardiology >Use of neutrophil‐lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study

【2h】

Use of neutrophil‐lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study

机译：中性粒细胞-淋巴细胞比率在非瓣膜性房颤患者治疗范围内的风险分层及其与时间的关系：一项先导研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAtrial fibrillation is one of the most common abnormal heart rhythms. Neutrophil‐lymphocyte ratio (NLR) has emerged as a potential marker for the level of inflammation in cardiac disorders.

机译：背景心房颤动是最常见的异常心律之一。中性粒细胞-淋巴细胞比率（NLR）已成为心脏疾病炎症水平的潜在标志。

著录项

期刊名称 Clinical Cardiology
作者
Kahraman Cosansu; Mehmet Bulent Vatan; Huseyin Gunduz; Ramazan Akdemir;
展开▼
作者单位

展开▼
年(卷),期 2018(41),3
年度 2018
页码 339–342
总页数 4
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Atrial Fibrillation Bleeding Neutrophil‐Lymphocyte Ratio Stroke Time in Therapeutic Range;

机译：心房纤颤;出血;中性粒细胞-淋巴细胞比率;中风;治疗时间;

相似文献

外文文献
中文文献
专利

1. Use of neutrophil‐lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study [J] . Kahraman Cosansu, Mehmet Bulent Vatan, Huseyin Gunduz, Clinical cardiology. . 2018,第3期

机译：非瓣膜性心房颤动患者中性粒细胞与淋巴细胞比例在治疗范围内的风险分层及其与时间的关系：一项先导研究
2. Neutrophil-Lymphocyte Ratio May Predict Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation [J] . Yalcin Murat, Aparci Mustafa, Uz Omer, Clinical and applied thrombosis/hemostasis . 2015,第2期

机译：非瓣膜性心房颤动患者中性粒细胞-淋巴细胞比率可能预测左心房血栓形成
3. Neutrophil–Lymphocyte Ratio May Predict Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation [J] . Murat Yalcin, Mustafa Aparci, Omer Uz, Clinical and applied thrombosis/hemostasis : . 2015,第2期

机译：非瓣膜性心房颤动患者中性粒细胞-淋巴细胞比率可能预测左心房血栓形成
4. Association between neutrophil to lymphocyte ratio on admission and grace mortality risk score among acute myocardial infarction patient at BRSUD Tabanan in 2017 [C] . P G E A Suyasa Annual Applied Science and Engineering Conference . 2019

机译：2017年Brsud Tabanan在Brsud Tabanan的急性心肌梗死患者入院和良好死亡率患者的淋巴细胞比率之间的联系
5. Dabigatran versus warfarin for the prevention of stroke in patients with chronic nonvalvular atrial fibrillation. [D] . Qiu, Fen. 2011

机译：达比加群与华法林预防慢性非瓣膜性房颤患者的中风。
6. Low Performance of a Clinical-Genetic Model in the Estimation of Time in Therapeutic Range in Acenocoumarol-Adherent Patients with Nonvalvular Atrial Fibrillation: The Quality of Anticoagulation Challenge [O] . Samantha Wasniewski, Luciano Consuegra-Sánchez, Pablo Conesa-Zamora, -1

机译：临床遗传模型的估计时间的估计范围在非瓣膜性心房颤动患者接受乙酰香豆酚的治疗范围内的低性能：抗凝挑战的质量
7. Use of neutrophil-lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study [O] . Kahraman Cosansu, Mehmet Bulent Vatan, Huseyin Gunduz, 2018

机译：使用中性粒细胞淋巴细胞比率对非衰弱性心房颤动患者的风险分层与风险分层的关系：试验研究

Use of neutrophil‐lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study

摘要

著录项

相似文献

相关主题

期刊订阅